Washington Post Examines Treatment Of MSM, WSW In Mexico, Latin America, Ability To Access HIV Treatment, Seek Asylum In U.S. Asylum applicants, U.S. lawyers and Hispanic advocates say it has become increasingly difficult for men who have sex with men and women who have sex with women from Mexico and other Latin American countries to obtain asylum in the U.S. because of the countries' improved treatment of homosexuality, liberalized laws and expanded HIV/AIDS treatment, according to the
Source: www.medicalnewstoday.comAdvanced Laparoscopic Techniques And The Use Of Harmonic(R) Technology In Gynecologic Surgery Join surgeons, Dr. Roger Ferland and Dr. Lori Warren, for a free one-hour live webcast highlighting the use of minimally invasive techniques in gynecologic surgery. The doctors will focus on the patient benefits of two approaches, Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy.
Source: www.medicalnewstoday.comU.S. NCI Starts Enrolment In Phase 2 Systemic Melanoma Clinical Trial With REOLYSIN(R) Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that the U.S. National Cancer Institute (NCI), part of the National Institutes of
Health, has started enrolment in a Phase 2 clinical trial for patients with metastatic melanoma using systemic administration of REOLYSIN(R), Oncolytics' proprietary formulation of the human reovirus.
Source: www.medicalnewstoday.comDuska Therapeutics Receives Comments From FDA On Phase 3 ATPace(TM) Protocol Synopsis Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) ("Duska") announced that it has received comments from the U.S. Food and Drug Administration's (the "FDA") Division of Cardiovascular and Renal Products on a synopsis of a proposed Phase 3 clinical study with its lead drug, ATPace(TM), for the acute treatment of a frequent cardiac arrhythmia called paroxysmal supraventricular tachycardia (PSVT).
Source: www.medicalnewstoday.comMedImmune Initiates First Phase 2 Trial In Lupus Patients With Its Antibody Targeting Interferon-alpha MedImmune announced that it has initiated enrollment in a Phase 2A trial with an investigational human monoclonal antibody (MAb) targeting interferon-alpha in patients with systemic lupus erythematosus (SLE or lupus). The study is designed to assess the safety and tolerability of the antibody, also known as MEDI-545 in patients with moderately to severely active lupus, despite standard of care.
Source: www.medicalnewstoday.comFemale Condom Skills Training Reduces Unprotected Sex Acts Among Women Using a randomized trial with a sample of 409 U.S. women recruited from family planning clinics in northern California, researchers tested the hypothesis that female condom skills training would successfully lead to an increase in sustained use of female condoms and protected sex.
Source: www.medicalnewstoday.com
# posted by Network @ 2:00 PM
